Insmed INSM
NASDAQ INSM
$126.29 -0.39 (-0.31%)
At close: Sep 4, 2026 · 4:00 PM EDT

Insmed (INSM) Current Assets (2010 - 2026)

Insmed (INSM) posted Current Assets of $1.6 billion for Q2 2026, up 1.29% on a QoQ basis from $1.6 billion in Q1 2026, and down 21.51% year-over-year from $2.1 billion in Q2 2025.

Analysis

Insmed (INSM) Current Assets (2010 - 2026) Analysis & Trends

Insmed has reported Current Assets for 17 years, with the latest figure at $1.6 billion in Q2 2026.

  • On a quarterly basis, Current Assets fell 21.51% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $1.6 billion, a 21.51% decrease from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 10.64% from the prior year.
  • Current Assets was $1.6 billion for Q2 2026 at Insmed, up from $1.6 billion in the prior quarter.
  • The five-year high for Current Assets was $2.1 billion in Q2 2025, with the low at $632.2 million in Q3 2022.
  • Average Current Assets over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2022.
  • The sharpest annual moves came in 2022 and 2025: Current Assets sank 35.01% in 2022, then soared 84.88% in 2025.
  • Over 5 years, Current Assets stood at $1.3 billion in 2022, then declined by 27.04% to $929.1 million in 2023, then surged by 74.55% to $1.6 billion in 2024, then grew by 10.64% to $1.8 billion in 2025, then retreated by 8.93% to $1.6 billion in 2026.
  • The last three Current Assets figures came in at $1.6 billion (Q2 2026), $1.6 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 18.45 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 8.07 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.82 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 4.62 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 7.31 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 1.63 Bn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn 17.78 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.63 Bn
Mar 31, 2026 1.61 Bn
Dec 31, 2025 1.79 Bn
Sep 30, 2025 1.93 Bn
Jun 30, 2025 2.08 Bn
Mar 31, 2025 1.40 Bn
Dec 31, 2024 1.62 Bn
Sep 30, 2024 1.65 Bn
Jun 30, 2024 1.42 Bn
Mar 31, 2024 758.72 Mn
Dec 31, 2023 929.06 Mn
Sep 30, 2023 926.58 Mn
Jun 30, 2023 1.05 Bn
Mar 31, 2023 1.13 Bn
Dec 31, 2022 1.27 Bn
Sep 30, 2022 632.17 Mn
Jun 30, 2022 674.73 Mn
Mar 31, 2022 756.14 Mn
Dec 31, 2021 837.04 Mn
Sep 30, 2021 958.98 Mn